Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

BACKGROUND: Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae has become a public health concern. This study aimed to compare the clinical outcomes of patients with nonurinary source bacteraemia caused by ESBL-producing Escherichia coli (E. coli) or Klebsiella pneumoniae (ESBL-produc...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hong, Xiao, Yanping, Hang, Yaping, Chen, Yanhui, Zhu, Hongying, Fang, Xueyao, Cao, Xingwei, Zou, Shan, Hu, Xiaoyan, Xiong, Jianqiu, Zhong, Qiaoshi, Hu, Longhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422674/
https://www.ncbi.nlm.nih.gov/pubmed/34488786
http://dx.doi.org/10.1186/s12941-021-00471-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422674/
https://www.ncbi.nlm.nih.gov/pubmed/34488786
http://dx.doi.org/10.1186/s12941-021-00471-6

Ejemplares similares